Not applicableStudy completedNCT06408454
What this trial is testing
Interleukin- 17 (IL-17), Bcl-3, and NF-kappa-B Inhibitor Zeta (IκBζ) Expression Levels in the Psoriasis Patients
Who this might be right for
PsoriasisPeriodontal Diseases
Kahramanmaras Sutcu Imam University 12